| Exogenous nitric oxide improves antibiotic susceptibility in resistant bacteria KR Rouillard, OP Novak, AM Pistiolis, L Yang, MJR Ahonen, ... ACS Infectious Diseases 7 (1), 23-33, 2020 | 56 | 2020 |
| Mode of nitric oxide delivery affects antibacterial action JR Hall, KR Rouillard, DJ Suchyta, MD Brown, MJR Ahonen, ... ACS biomaterials science & engineering 6 (1), 433-441, 2019 | 55 | 2019 |
| Antimicrobial effects of nitric oxide in murine models of Klebsiella pneumonia SB Wiegand, L Traeger, HK Nguyen, KR Rouillard, A Fischbach, F Zadek, ... Redox biology 39, 101826, 2021 | 37 | 2021 |
| Pseudomonas aeruginosa Biofilm Eradication via Nitric Oxide-Releasing Cyclodextrins KR Rouillard, MR Markovetz, LG Bacudio, DB Hill, MH Schoenfisch ACS Infectious Diseases 6 (7), 1940-1950, 2020 | 22 | 2020 |
| Effects of mucin and DNA concentrations in airway mucus on Pseudomonas aeruginosa biofilm recalcitrance KR Rouillard, WJ Kissner, MR Markovetz, DB Hill Msphere 7 (4), e00291-22, 2022 | 16 | 2022 |
| Antibiofilm and mucolytic action of nitric oxide delivered via gas or macromolecular donor using in vitro and ex vivo models KR Rouillard, DB Hill, MH Schoenfisch Journal of Cystic Fibrosis 19 (6), 1004-1010, 2020 | 16 | 2020 |
| Altering the viscoelastic properties of mucus-grown Pseudomonas aeruginosa biofilms affects antibiotic susceptibility KR Rouillard, MR Markovetz, WJ Kissner, WL Boone, LM Plott, DB Hill Biofilm 5, 100104, 2023 | 6 | 2023 |
| Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto MH Schoenfisch, MJR Ahonen, DJ Suchyta, KR Rouillard US Patent 11,072,668, 2021 | 6 | 2021 |
| Delivery characterization of SPL84 inhaled antisense oligonucleotide drug for 3849+ 10 kb C-> T cystic fibrosis patients E Ozeri-Galai, L Friedman, O Barchad-Avitzur, MR Markovetz, W Boone, ... nucleic acid therapeutics 33 (5), 306-318, 2023 | 5 | 2023 |
| Delivery Characterization of SPL84 Inhaled Antisense Oligonucleotide E Ozeri-Galai, L Friedman, MR Markovetz, W Boone, KR Rouillard, ... MedRxiv, 2023.01. 09.23284328, 2023 | 1 | 2023 |
| 506: Effects of mucin and DNA concentrations in mucus on Pseudomonas aeruginosa biofilm recalcitrance K Rouillard, S Maloney, W Kissner, M Markovetz, M Schoenfisch, D Hill Journal of Cystic Fibrosis 20, S239, 2021 | 1 | 2021 |
| Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto MH Schoenfisch, MJR AHONEN, DJ SUCHYTA, KR ROUILLARD | 1 | 2018 |
| Ethanol alters e-liquid physicochemical properties, toxicity, and nicotine deposition MGS Biggart, J Wrennall, M Strenta, K Rouillard, D Hill, R Tarran B70. COPD IN THE SPOTLIGHT: INSIGHTS INTO DISEASE PATHOGENESIS, A4309-A4309, 2024 | | 2024 |
| Mucus polymer concentration and in vivo adaptation converge to define the antibiotic response of Pseudomonas aeruginosa during chronic lung infection MA Greenwald, SL Meinig, LM Plott, C Roca, MG Higgs, NP Vitko, ... Mbio, e03451-23, 2024 | | 2024 |
| Combination treatment to improve mucociliary transport of Pseudomonas aeruginosa biofilms KR Rouillard, CP Esther, WJ Kissner, LM Plott, DW Bowman, ... Plos one 19 (2), e0294120, 2024 | | 2024 |
| Endotracheal Tube Mucus for the Growth and Analysis of Pseudomonas aeruginosa Biofilms K Rouillard, DB Hill | | 2023 |
| 186 Quantifying mucus rheological properties and permeability with step size variance particle tracking microrheology F Fazelpour, K Rouillard, W Kissner, L Plott, M Markovetz, D Hill Journal of Cystic Fibrosis 22, S97, 2023 | | 2023 |
| Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto MH Schoenfisch, MJR Ahonen, DJ Suchyta, KR Rouillard US Patent 11,697,693, 2023 | | 2023 |
| WS09. 03 Delivery characterisation of SPL84 Inhaled Antisense Oligonucleotide E Ozeri-Galai, L Friedman, M Markovetz, W Boone, G Hart, K Rouillard, ... Journal of Cystic Fibrosis 22, S18-S19, 2023 | | 2023 |
| Exogenous nitric oxide for improved susceptibility and lowered antibiotic resistance in resistant respiratory bacteria MH Schoenfisch, KR Rouillard US Patent App. 17/799,871, 2023 | | 2023 |
